Streetbeat News

Price Targets

CYTK

Goldman Sachs has downgraded Cytokinetics (NASDAQ:CYTK) from Buy to Neutral and lowered the price target from $85 to $60.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 9:13 am

TMUS

Tigress Financial analyst Ivan Feinseth maintains a Buy rating on T-Mobile US (NASDAQ:TMUS) and raises the price target from $205 to $235.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 11:06 pm

FDS

Wells Fargo has initiated coverage on FactSet Research Systems (NYSE:FDS) with an Equal-Weight rating and a price target of $435.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:48 pm

MSCI

Wells Fargo has initiated coverage on MSCI with an Equal-Weight rating and set a price target of $570.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:46 pm

IT

Wells Fargo has initiated coverage on Gartner (NYSE:IT) with an Underweight rating and set a price target of $435.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:45 pm

SPGI

Wells Fargo has initiated coverage on S&P Global (NYSE:SPGI) with an Overweight rating and a price target of $575.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:42 pm

CTAS

Wells Fargo has initiated coverage on Cintas (NASDAQ:CTAS) with an Underweight rating and set a price target of $735.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:40 pm

ROL

Wells Fargo has initiated coverage on Rollins (NYSE:ROL) with an Overweight rating and set a price target of $54.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:39 pm

EFX

Wells Fargo has initiated coverage on Equifax (NYSE:EFX) with an Overweight rating and set a price target of $340.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:37 pm

TRU

Wells Fargo has initiated coverage on TransUnion with an Overweight rating and set a price target of $100.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 10:35 pm